FREE TRIAL
LOGIN
LOGIN

NOVACYT S.A.

TRADE AIM SHARES
SEARCH COMPANIES
NOVACYT S.A. EUR1/15TH (CDI) NCYT.L · LSE
Live
GBP 0.43 – 0.00 (0.00%)
Mkt Cap £30.81M
Volume 15,760
52W 26.60 – 86.00
🔔 Sign in to receive sentiment alerts for NOVACYT S.A..
YOUR ALERTS

Market Sentiment

Sentiment Grade
C
↓ Declining (-4.4 pts vs 7-day avg)
NOVACYT S.A.
Positive Sentiment
5.7/10
Sentiment Index
Very NegativeNeutralVery Positive
69%
Avg Confidence
10 / 0
Positive / Negative articles
📰 Based on 39 articles from 16 sources Share Talk ×9 thearmchairtrader.com ×5 London Stock Exchange ×4 Investegate ×4 TradingView ×3
📊 Low volatility — MEVI 7.7/100
🕐 Updated 7 hours ago
Today's context

Daily AI-generated context for this company — recent events, market backdrop, and supporting developments. Available to Pro Investor members.

📊
Full Analysis Available to Paid Members
Paid members get full access to detailed sentiment charts, article-level analysis, social media sentiment, confidence breakdowns, and historical trends and sentiment outlook on all companies on the site.
Sign in Register

Latest RNS & Market News

  • NOVACYT S.A. – Half Year Trading Update
    RNS Number : 9972N Novacyt S.A. 28 July 2026       Novacyt S.A. (“Novacyt”, the “Company” or the “Group”)   Half-year trading update   Paris, France, and Manchester, UK – 28 July 2026 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and…
  • NOVACYT S.A. – 1. Corporate Information
    RNS Number : 4829C Novacyt S.A. 30 April 2026     Novacyt S.A. (“Novacyt”, the “Company” or the “Group”)   Full Year 2025 results   Paris, France, and Manchester, UK – 30 April 2026 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and…
LOGIN

Search For A Company

RISK WARNING